NIH-funded research Fellowship grant

Investigating the immune cells involved in type I diabetes

Official title: Spatiotemporal and molecular determinants of autoimmune T cell stemness and differentiation in type I diabetes

Funded at Weill Medical Coll of Cornell Univ · NIH-10995900 · Data updated 2026-11-12

This study is looking at how certain immune cells, called CD8 T cells, play a role in causing type 1 diabetes, using a mouse model to learn more about how these cells can harm insulin-producing cells in the pancreas, with the hope of finding new ways to prevent or treat the disease.

More Diabetes research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 26, 2024
Project endAugust 25, 2027
Funding year2024
Award (this year)$48,974
NIH project number1F31DK141119-01
Project IDNIH-10995900 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of developing type I diabetes or those who have recently been diagnosed.

Less likely to help

Patients with type II diabetes or other non-autoimmune forms of diabetes may not benefit from this research.

What this research studies

This research focuses on understanding how specific immune cells, particularly CD8 T cells, contribute to the development of type I diabetes (T1D). By using a mouse model that mimics human T1D, the researchers will explore the mechanisms that allow these immune cells to self-renew and differentiate, leading to the destruction of insulin-producing cells in the pancreas. The study employs advanced techniques such as imaging cytometry and spatial transcriptomics to gain insights into the cellular processes involved in this autoimmune disease. Ultimately, the goal is to identify potential targets for preventing or treating T1D by disrupting harmful immune responses.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating type I diabetes by targeting the immune mechanisms involved.

How similar studies have gone: Previous research has shown promising results in understanding autoimmune mechanisms in diabetes, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Miakicheva, Svetlana Dmitrievna — Weill Medical Coll of Cornell Univ
  • Study coordinator: Miakicheva, Svetlana Dmitrievna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.